Related references
Note: Only part of the references are listed.Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
Hebaallah Mamdouh Hashiesh et al.
FRONTIERS IN PHARMACOLOGY (2021)
Metabolism of vascular smooth muscle cells in vascular diseases
Jia Shi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors
Szabolcs Dvoracsko et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Novel Fubinaca/Rimonabant hybrids as endocannabinoid system modulators
Azzurra Stefanucci et al.
AMINO ACIDS (2018)
Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
Adriano Mollica et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Activation of type 2 cannabinoid receptor (CB2R) by selective agonists regulates the deposition and remodelling of the extracellular matrix
Tao Guan et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
Masato Morikawa et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Activation of Cannabinoid Type 2 Receptor by JWH133 Protects Heart Against Ischemia/Reperfusion-Induced Apoptosis
Qian Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome
Svetlana Slavic et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Cannabinoid receptor CB2 protects against balloon-induced neointima formation
Filippo Molica et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies
Sabine Steffens et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques
Fabrizio Montecucco et al.
EUROPEAN HEART JOURNAL (2012)
Cell metabolism: An essential link between cell growth and apoptosis
Emily F. Mason et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line
A. B. El-Remessy et al.
DIABETOLOGIA (2011)
TGF-beta suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB
George M. Risinger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice
Courtney D. Netherland et al.
ATHEROSCLEROSIS (2010)
Cleaved high molecular weight kininogen, a novel factor in the regulation of matrix metalloproteinases in vascular smooth muscle cells
Uwe Vosgerau et al.
BIOCHEMICAL PHARMACOLOGY (2010)
CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes
Partha Mukhopadhyay et al.
CARDIOVASCULAR RESEARCH (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy
Nicole Defer et al.
FASEB JOURNAL (2009)
Endocannabinoids and cardiac contractile function: Pathophysiological implications
Sandor Batkai et al.
PHARMACOLOGICAL RESEARCH (2009)
A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression
Carolyn L. Buller et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration
M. Rajesh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Matrix metalloproteinases (MMPs): Chemical-biological functions and (Q)SARs
Rajeshwar P. Verma et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
GLUT4 facilitative glucose transporter specifically and differentially contributes to agonist-induced vascular reactivity in mouse aorta
JL Park et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor
M Steffens et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Share Paper
